Hypoglycemia Clinical Trials 2024

Hypoglycemia Clinical Trials 2024

Hypoglycemia research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in hypoglycemia clinical trials today.

Hypoglycemia Clinical Trials

Here are the 6 most popular medical studies for hypoglycemia

Popular filter options for hypoglycemia trials

Low Blood Sugar Clinical Trials

View 31 Low Blood Sugar medical studies.

Type 1 Diabetes Clinical Trials

View 30 Type 1 Diabetes medical studies.

Hypoglycemia Clinical Trials With No Placebo

View 63 hypoglycemia medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to hypoglycemia

What are the top hospitals conducting hypoglycemia research?

When it comes to cutting-edge research on hypoglycemia, several hospitals are leading the way in advancing our understanding and treatment of this condition. In Boston, Brigham and Women's Hospital stands out with three active clinical trials focused on hypoglycemia. Over the years, they have contributed to a total of six trials since their first recorded trial in 2004. Moving across the country to Stanford University School of Medicine in Stanford, researchers there are also actively engaged in three ongoing hypoglycemia trials. With a history dating back to 2009, they have completed five trials thus far.

In Miami, the Diabetes Research Institute at the University of Miami Miller School of Medicine is making significant strides as well. This institute currently has three active clinical trials centered around hypoglycemia and entered into this area relatively recently with its first recorded trial occurring in 2014.

Further westward lies San Antonio where two institutions are pioneering research on hypoglycemia: The Texas Diabetes Institute - University Health System and South Texas Veterans Health Care System. Both facilities have an equal number of three ongoing experimental studies focusing on hypoglycemia.The former initiated its earliest investigation related to it about twelve years ago since recording a ground-breaking trial back until 2009 while latter has conductedthe same number involving such cases from that period as well.

These hospitals represent beacons of hope for individuals experiencing challenges associated with low blood sugar levels. Through their efforts and dedication toward combating hypoglycemia through innovative clinical trials, these medical centers bring us closer to uncovering improved treatments and management strategies for patients worldwide

Which are the best cities for hypoglycemia clinical trials?

When it comes to hypoglycemia clinical trials, several cities in the United States and Canada have emerged as hotspots for research. Boston, Massachusetts leads the pack with 10 active trials investigating various aspects of hypoglycemia including Spironolactone, structured physical activity for post-bariatric hypoglycemia patients, and more. San Antonio, Texas follows closely behind with 7 ongoing studies exploring treatments like GLP-1 and GIP, Atropine, and exendin-(9-39). Philadelphia, Pennsylvania also plays a significant role with 5 active trials focusing on technologies such as the MiniMed 670G system and therapeutic interventions like Propranolol Intra-hepatic islet. Lastly, Montreal in Quebec joins the list with 5 ongoing trials evaluating different strategies such as continuous exercise and standard educational programs for managing hypoglycemia. These cities offer valuable opportunities for individuals experiencing hypoglycemia to participate in cutting-edge clinical trials that contribute to improving care options in this field.

Which are the top treatments for hypoglycemia being explored in clinical trials?

In the realm of clinical trials for hypoglycemia, there are a few cutting-edge treatments that show promise in improving patient outcomes. Hypoglycemia Symptom Detection Training is currently being explored in one active trial and marks its debut on the scene in 2023. Another innovative approach involves Active Electronic Medical Record Inpatient Diabetes Clinical Decision Support, also undergoing investigation with one ongoing trial since 2022. Additionally, Continuous Glucose Monitoring has garnered attention with one active trial and seven all-time hypoglycemia trials since it was first listed back in 2012. These advancements hold potential to revolutionize how we address and manage hypoglycemic episodes moving forward.

What are the most recent clinical trials for hypoglycemia?

Exciting advancements are being made in the field of hypoglycemia research, with recent clinical trials offering new hope for patients. ZT-01 7 mg, a Phase 2 trial, has shown promise as a potential treatment for hypoglycemia. Another Phase 2 trial called Cohort 1 is also underway to evaluate its efficacy in managing this condition. Additionally, Dasiglucagon 0.6 mg is currently undergoing a Phase 3 trial to assess its effectiveness in treating hypoglycemia. These breakthroughs bring us closer to finding innovative solutions and improving the lives of those affected by hypoglycemia.

What hypoglycemia clinical trials were recently completed?

Recently, two significant clinical trials investigating potential treatments for hypoglycemia have reached completion. In September 2022, Vogenx, Inc. successfully concluded a trial involving Mizagliflozin. Likewise, in June 2021, Dr. Tracey McLaughlin's study on Avexitide was finalized. These exciting advancements bring hope for individuals affected by hypoglycemia as researchers continue to explore innovative therapeutic options to improve their quality of life and overall well-being.